HGHSX Mutual Fund

NAV$41.94

Fund Essentials - as of Oct 31, 2025

Net Assets
$8M
Expense Ratio
1.31%
Dividend Yield (Current)
3.17%
Holdings
77
Inception Date
Dec 22, 2006
Fund Family
Hartford Funds
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+0.91%
1 Year+13.62%
3 Year+8.59%
5 Year+5.43%
10 Year+13.34%

Asset Allocation

Stocks: 99.35%
Bonds: 0.33%
Cash: 0.32%

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co12.98%
UNHUnitedHealth Group Incorporated5.84%
ABBVAbbvie Inc4.69%
JNJJohnson & Johnson4.48%
MRKMerck & Company Inc4.22%
Top 10 Concentration: 48.49%Report Date: Oct 31, 2025
Download all 77 holdings for HGHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
3.17%
Frequency
Annually

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

HGHSX Mutual Fund Overview

HGHSX Mutual Fund (The Hartford Healthcare Fund Cl R4) is managed by Hartford Funds with $7.9M in net assets. HGHSX expense ratio is 1.31%, holding 77 positions across sectors including Health Care, Unknown, Financials. Inception date: 2006-12-22.

HGHSX performance shows a YTD return of 0.91%. The 1-year return is 13.62% and the 5-year return is 5.43%. HGHSX dividend yield stands at 3.17%, paid annually.

HGHSX top holdings include Eli Lilly & Co (13.0%), UnitedHealth Group Incorporated (5.8%), Abbvie Inc (4.7%), Johnson & Johnson (4.5%), Merck & Company Inc (4.2%). View all HGHSX holdings, sector breakdown, or dividend history.

HGHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HGHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.